marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q3
added 11-21-2022
Applied Genetic Technologies Corporation Balance Sheet 2011-2024 | AGTC
Annual Balance Sheet Applied Genetic Technologies Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-36 M | -86.2 M | -27.7 M | -26.7 M | -31.1 M | -30.7 M | -28.9 M | -39.2 M | -8.62 M | -19.6 M | 249 K | - |
Long Term Debt |
9.12 M | 17.7 M | 9.68 M | - | - | - | - | - | - | - | 16 K | - |
Long Term Debt Current |
1.27 M | 1.12 M | 1.06 M | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 4.15 M | 4.96 M | 4.44 M | 16.8 M | - | - | - | 32.6 M | - |
Total Current Liabilities |
25.2 M | 19.7 M | 13 M | 9.36 M | 14.4 M | 28.2 M | 54.7 M | 4.64 M | 2.53 M | - | - | - |
Total Liabilities |
37.2 M | 41.2 M | 29.3 M | 13.5 M | 19.4 M | 32.6 M | 71.5 M | 4.64 M | 2.53 M | 1.36 M | 34.1 M | - |
Deferred Revenue |
- | - | - | - | 6.3 M | 21 M | 46.9 M | - | - | 212 K | - | - |
Retained Earnings |
-308 M | -239 M | -181 M | -136 M | -111 M | -89.6 M | -90 M | -88.7 M | -64.3 M | -48.4 M | -43.4 M | - |
Total Assets |
66.7 M | 127 M | 100 M | 92.2 M | 119 M | 148 M | 181 M | 90.2 M | 77.4 M | 36.2 M | 2.82 M | - |
Cash and Cash Equivalents |
46.4 M | 105 M | 38.5 M | 26.7 M | 31.1 M | 30.7 M | 28.9 M | 39.2 M | 8.62 M | 8.89 M | 774 K | - |
Book Value |
29.5 M | 85.8 M | 71 M | 78.7 M | 99.2 M | 115 M | 109 M | 85.5 M | 74.9 M | 34.8 M | -31.3 M | - |
Total Shareholders Equity |
29.5 M | 85.8 M | 71 M | 78.7 M | 99.2 M | 115 M | 109 M | 85.5 M | 74.9 M | -36.2 M | -31.3 M | - |
All numbers in USD currency
Quarterly Balance Sheet Applied Genetic Technologies Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 6.81 M | 9.12 M | 11.4 M | 13.5 M | 15.7 M | 17.7 M | 17.7 M | 9.84 M | 9.76 M | 9.68 M | 9.68 M | 63 K | 75 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | 39.7 M | 37.2 M | 40.2 M | 40.9 M | 40.9 M | 41.2 M | 41.2 M | 30.4 M | 29.4 M | 29.3 M | 29.3 M | 22.2 M | 16.7 M | 13.5 M | 13.5 M | 32.1 M | 38.4 M | 19.4 M | 19.4 M | 19.8 M | 23.6 M | 32.6 M | 32.6 M | 48 M | 58.9 M | 71.5 M | 71.5 M | 94.1 M | 113 M | 4.64 M | 4.64 M | 2.72 M | 3.24 M | 2.53 M | 2.53 M | - | 3.57 M | 3.57 M | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 12.7 M | 16.3 M | 6.3 M | 8.19 M | 11.9 M | 14.7 M | 21 M | 21 M | - | - | 46.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | -327 M | -308 M | -290 M | -276 M | -256 M | -239 M | -239 M | -212 M | -197 M | -181 M | -181 M | -156 M | -147 M | -136 M | -136 M | -137 M | -132 M | -111 M | -111 M | -96.2 M | -91 M | -89.6 M | -89.6 M | -84.3 M | -86.4 M | -90 M | -90 M | -94.7 M | -97.8 M | -88.7 M | -88.7 M | -74.4 M | -69.7 M | -64.3 M | -64.3 M | - | -48.4 M | -48.4 M | - | - | - | - | - | - | - | - | - |
Total Assets |
- | 57.3 M | 66.7 M | 87.2 M | 92.4 M | 110 M | 127 M | 127 M | 72 M | 85.6 M | 100 M | 100 M | 82.3 M | 84.6 M | 92.2 M | 92.2 M | 108 M | 117 M | 119 M | 119 M | 131 M | 139 M | 148 M | 148 M | 166 M | 173 M | 181 M | 181 M | 196 M | 210 M | 90.2 M | 90.2 M | 101 M | 105 M | 77.4 M | 77.4 M | - | 25.5 M | 25.5 M | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | 34.2 M | 46.4 M | 67.8 M | 72.8 M | 90.5 M | 105 M | 105 M | 19.1 M | 31.6 M | 38.5 M | 38.5 M | 18.1 M | 16.3 M | 26.7 M | 26.7 M | 24 M | 26.5 M | 31.1 M | 31.1 M | 70.3 M | 48.7 M | 30.7 M | 30.7 M | 42.5 M | 56 M | 42.5 M | 56 M | 44.4 M | 140 M | 44.4 M | 140 M | 44.2 M | 46.8 M | 44.2 M | 46.8 M | 9 M | 7.86 M | 8.89 M | 5.56 M | - | - | 774 K | - | - | - | 1.83 M | - |
Book Value |
- | 17.6 M | 29.5 M | 47 M | 51.5 M | 69.5 M | 85.8 M | 85.8 M | 41.5 M | 56.2 M | 71 M | 71 M | 60 M | 68 M | 78.7 M | 78.7 M | 76 M | 78.9 M | 99.2 M | 99.2 M | 112 M | 115 M | 115 M | 115 M | 118 M | 114 M | 109 M | 109 M | 102 M | 97.4 M | 85.5 M | 85.5 M | 98.1 M | 102 M | 74.9 M | 74.9 M | - | 21.9 M | 21.9 M | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | 17.6 M | 29.5 M | 47 M | 51.5 M | 69.5 M | 51.5 M | 69.5 M | 41.5 M | 41.5 M | 41.5 M | 56.2 M | 60 M | 60 M | 60 M | 68 M | 76 M | 76 M | 76 M | 78.9 M | 112 M | 115 M | 112 M | 115 M | 118 M | 114 M | 109 M | 109 M | 102 M | 97.4 M | 85.5 M | 85.5 M | 98.1 M | 102 M | 74.9 M | 74.9 M | - | -36.2 M | -36.2 M | - | - | - | -31.3 M | - | - | - | -29.4 M | - |
All numbers in USD currency